Varga-Szemes, Akos
Penmetsa, Megha
Emrich, Tilman
Todoran, Thomas M.
Suranyi, Pal
Fuller, Stephen R.
Edelman, Robert R.
Koktzoglou, Ioannis
Schoepf, U. Joseph http://orcid.org/0000-0002-6164-5641
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01 HL130093)
Siemens USA (n/a)
Article History
Received: 20 March 2020
Revised: 4 June 2020
Accepted: 7 October 2020
First Online: 17 October 2020
Compliance with ethical standards
:
: The scientific guarantor of this publication is U. Joseph Schoepf.
: The authors of this manuscript declare relationships with the following companies: U. Joseph Schoepf is a consultant for and/or receives research support from Astellas, Bayer, Elucid Bioimaging, Guerbet, HeartFlow Inc., and Siemens Healthcare. Akos Varga-Szemes receives institutional research and travel support from Siemens Healthcare and is a consultant for Elucid Bioimaging. Robert R. Edelman receives grant support and royalties from Siemens Healthcare. Ioannis Koktzoglou receives research support from Siemens Healthcare.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: • prospective• diagnostic or prognostic study• performed at one institution